April 2022: ACR announces new version 1.6 of the Lung Cancer Screening Registry (LCSR)
Lung cancer kills more people each year than breast, colorectal and prostate cancer combined. Annual lung cancer screening with low-dose computed tomography (LDCT) in high-risk patients significantly reduces lung cancer deaths.,
Yet, less than 15% of Americans who met previous criteria are tested., The American Cancer Society predicts 131,180 lung cancer deaths in 2022. More-widespread screening could save 30,000–60,000 lives in the United States each year.
Two big changes happened recently. First, Medicare lowered the recommended age for Screening from 50 to 55, and the American College of Radiology (ACR) has updated it’s Lung Cancer Screening Registry (LCSR) to Version 1.6, and beginning the end of September 2022, will not accept older versions.
Omnicare for Lung, a widely used platform to help manage lung screening and pulmonary nodule patients, has been licensed by the ACR for LungRads and the LCSR, since it’s inception and complies with all Medicare data collection requirements. Clients using OmniCare Version 8 will meet this new LCSR requirement.
If you have an older version of OmniCare or are looking for a solution to help you build and grow your Lung Screening Program, contact us at 800-643-0123